Ondansetron Compared with Dexamethasone and Metoclopramide as Antiemetics in the Chemotherapy of Breast Cancer with Cyclophosphamide, Methotrexate, and Fluorouracil

New England Journal of Medicine

Volumn 328, Issue 15, 1993, Pages 1081-1084

  Levitt, Martin ^b   Warr, David ^c   Yelle, Louise ^f   Rayner, Harry L ^h   Lofters, Wycliffe S ⁱ   Perrault, Danielle J ^k   Wilson, Kenneth S ^h   Latreille, Jean ^a   Potvin, Martin ^l   Warner, Ellen ^d   Pritchard, Kathleen I ^e   Palmer, Michael ^j   Zee, Benny ^j   Pater, Joseph L ^g,j  

^a Manitoba Cancer Treatment and Research Foundation ^*

^b UNIVERSITY OF MANITOBA   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e Cancer Centre   (Canada)

^f NOTRE DAME HOSPITAL   (Canada)

^g CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^h BRITISH COLUMBIA CANCER AGENCY   (Canada)

ⁱ Kingston Regional Cancer Center   (Canada)

^j Queen's Cancer Research Institute   (Canada)

^k OTTAWA REGIONAL CANCER CENTRE   (Canada)

^l LAVAL UNIVERSITY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; FLUOROURACIL; METHOTREXATE; METOCLOPRAMIDE; ONDANSETRON; PROCHLORPERAZINE;

ADULT; ANTIEMETIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VOMITING;

ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COMPARATIVE STUDY; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DRUG THERAPY, COMBINATION; FEMALE; FLUOROURACIL; HUMAN; METHOTREXATE; METOCLOPRAMIDE; MIDDLE AGE; NAUSEA; ONDANSETRON; REGRESSION ANALYSIS; SUPPORT, NON-U.S. GOV'T; VOMITING;

EID: 0027461853     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199304153281503     Document Type: Article

References (17)

1. Hainsworth J, Harvey W, Pendergrass K, A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy. J Clin Oncol 1991; 9:721-728
2. Hesketh PJ, Gandara D Serotonin antagonists: a new class of antiemetic agents. J Natl Cancer Inst 1991; 83:613-620
3. Cubeddu LX, Hoffman IS, Fuenmayor NT, Finn AL Antagonism of serotonin S3 receptors with ondansetron prevents nausea and emesis induced by cyclophosphamide-containing chemotherapy regimens. J Clin Oncol 1990; 8:1721-1727
4. Bonneterre J, Chevallier B, Metz R, A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy. J Clin Oncol 1990; 8:1063-1069
5. De Mulder PHM, Seynaeve C, Vermorken JB, Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting: a multicenter, randomized, double-blind, crossover study. Ann Intern Med 1990; 113:834-840
6. 3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis. N Engl J Med 1990; 322:816-821
7. Grunberg SM Making chemotherapy easier. N Engl J Med 1990; 322:846-848
8. Canellos GP, Pocock SJ, Taylor SG III, Sears ME, Klaasen DJ, Band PR Combination chemotherapy for metastatic breast carcinoma: prospective comparison of multiple drug therapy with L-phenylalanine mustard. Cancer 1976; 38:1882-1886
9. Fetting JH, Grochow LB, Folstein MF, Ettinger DS, Colvin M The course of nausea and vomiting after high-dose cyclophosphamide. Cancer Treat Rep 1982; 66:1487-1493
10. Willan AR, Warr D, Pater JL, Levitt M, Erlichman C, Osoba D. Methodological issues in anti-emetic studies. In: Osoba D, ed. Effect of cancer on quality of life. Boca Raton, Fla.: CRC Press, 1991:229-49.
11. Landis JR, Miller ME, Davis CS, Koch GG Some general methods for the analysis of categorical data in longitudinal studies. Stat Med 1988; 7:109-137
12. Andrews DF, Gnanadesikan R, Warner JL Transformations of multivariate data. Biometrics 1971; 27:825-840
13. Buser K, Joss R, Piquet D, A randomized, double-blind comparison of oral ondansetron and placebo in the prophylaxis of CMF-induced nausea and vomiting. Proc Am Soc Clin Oncol 1990; 9:331-331 abstract.
14. Roila F, Tonato M, Cognetti F, Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone. J Clin Oncol 1991; 9:675-678
15. Tannock IF, Boyd NF, DeBoer G, A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer. J Clin Oncol 1988; 6:1377-1387
16. Jones AL, Hill AS, Soukop M, Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy. Lancet 1991; 338:483-487
17. Pater JL, Slamet L, Zee B, Osoba D, Warr D, Rusthoven J Inconsistency of prognostic factors or post chemotherapy nausea and vomiting (PNV). Eur J Cancer 1991; 27: Suppl 2: S298-S298 abstract.